Oxford Biomedica Plc (OXB.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -21,658 | -33,338 | 28,793 | -17,876 | 6,891 |
| Other Working Capital | 3,230 | -34,383 | 17,457 | 4,932 | -12,909 |
| Other Operating Activity | 18,935 | 17,055 | -74,767 | 329 | 31,473 |
| Operating Cash Flow | $507 | $-50,666 | $-28,517 | $-12,615 | $25,455 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,761 | -7,496 | -1,442 | 43,704 | -9,461 |
| Net Acquisitions | -3,337 | 9,004 | 0 | -99,206 | N/A |
| Other Investing Activity | 2,375 | 4,124 | 4,248 | -960 | 0 |
| Investing Cash Flow | $-5,723 | $5,632 | $2,806 | $-56,462 | $-9,461 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 41,954 | N/A | 0 | 64,866 | N/A |
| Debt Repayment | -38,774 | -466 | 0 | -31,424 | N/A |
| Common Stock Issued | 58,058 | 17,526 | 651 | 80,154 | 51,600 |
| Other Financing Activity | -18,978 | -14,152 | -13,354 | -14,974 | -5,393 |
| Financing Cash Flow | $42,260 | $2,908 | $-12,703 | $98,622 | $46,207 |
| Exchange Rate Effect | -810 | -940 | 845 | 2,796 | N/A |
| Beginning Cash Position | 60,650 | 103,716 | 141,285 | 108,944 | 46,743 |
| End Cash Position | 96,884 | 60,650 | 103,716 | 141,285 | 108,944 |
| Net Cash Flow | $37,044 | $-42,126 | $-38,414 | $29,545 | $62,201 |
| Free Cash Flow | |||||
| Operating Cash Flow | 507 | -50,666 | -28,517 | -12,615 | 25,455 |
| Capital Expenditure | -4,761 | -7,496 | -9,832 | -16,296 | -9,461 |
| Free Cash Flow | -4,254 | -58,162 | -38,349 | -28,911 | 15,994 |